Cofepris alerts for illegal sale of ‘fake’ medicines against COVID-19

The Federal Commission for the Protection against Sanitary Risks (Cofepris) issued a health alert for the commercialization of counterfeit medicines ivermectina e ivermin.

The agency noted that this was determined after receiving the complaint from Grossman Laboratories

“Laboratorios Grossman SA, carried out a comparative analysis of the products and concluded that they are counterfeit,” he said in a statement.

The false belief is related to ivermectin. Around June, it became known about two studies that indicated that this drug had been used successfully against the SARS-CoV-2 virus.

The document indicated that in vitro in experimentally infected cells.

Two publications stated that these tests had demonstrated the usefulness of the drug against the new coronavirus in patients who had required to be connected to ventilators.

The problem? These were not medically peer revieweds nor were they formally published.

Therefore, in July, the Ministry of Health warned the population that there was no scientific evidence that ivermectin, along with another series of medications, it should be used to treat COVID-19 patients.

In fact, ivermectin can cause side effects like headache, allergies and diarrhea, warned Alethse de la Torre Rosas, general director of the National Center for the Prevention and Control of HIV.

It may interest you: Do you have symptoms of COVID-19? We give you two good reasons not to self-medicate

Cofepris indicated that you will find the following information on fake drugs:

-Ivermectin: lot number 382820; expiration date DEC 22, 2022; bottle 4 tablets, without health registration.

-Ivermin: lot number SC2025; expiration date JUN 2023; bottle 4 tablets; sanitary registration 566M2001 SSA IV.

We recommend you:

COVID traffic light in Mexico: your status will be at this level from November 23 to December 6

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.